| Detailed information |
|---|
| CancerLivER ID | 2114 |
| Biomarker | pyruvic acid |
| Biomarker Name/Symbol (given in Publication) | pyruvic acid in urine |
| Biomolecule | Metabolite |
| Subject | Human |
| Degree of Validity | Biomarkers for diabetic II and liver cancer; but not validated on independent dataset |
| Experimental Condition | Normal vs cancer |
| Cancer type | Human liver cancer and diabetic |
| Regulation | The concentrations of PA in diabetic II and liver cancer urine samples were significantly lower than those from healthy people. |
| Level of significance | p < 0.05 |
| Source | Urine |
| PMID | 25871588 |
| Type of Biomarker | Diagnostic |
| Pathway | Metabolic pathway |
| Cohort | Urine samples were obtained from 18 volunteers ( five healthy, four diabetic and nine liver cancer). |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human diabetic , liver cancer |
| Year of Publication | 2015 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |